Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence, analgesia or desired therapeutic response is not received.

According to this study, over the next five years the Opioid Tolerance Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Opioid Tolerance Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Tolerance Treatment market by product type, application, key manufacturers and key regions and countries.

This study considers the Opioid Tolerance Treatment value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

NMDA Antagonists

Alpha2-Adrenoceptor Agonists

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Hospitals and Ambulatory Surgery Centers

Rehabilitation Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Boehringer Ingelheim International

GlaxoSmithKline

Teva Pharmaceutical Industries

Mylan

Otsuka Pharmaceutical

Johnson & Johnson Services

Aurobindo Pharma

Pfizer

Acorda Therapeutics

Zydus Cadila

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Opioid Tolerance Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Opioid Tolerance Treatment market by identifying its various subsegments.

Focuses on the key global Opioid Tolerance Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Opioid Tolerance Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Opioid Tolerance Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Opioid Tolerance Treatment Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioid Tolerance Treatment Consumption 2014-2024

2.1.2 Opioid Tolerance Treatment Consumption CAGR by Region

2.2 Opioid Tolerance Treatment Segment by Type

2.2.1 NMDA Antagonists

2.2.2 Alpha2-Adrenoceptor Agonists

2.3 Opioid Tolerance Treatment Consumption by Type

2.3.1 Global Opioid Tolerance Treatment Consumption Market Share by Type (2014-2019)

2.3.2 Global Opioid Tolerance Treatment Revenue and Market Share by Type (2014-2019)

2.3.3 Global Opioid Tolerance Treatment Sale Price by Type (2014-2019)

2.4 Opioid Tolerance Treatment Segment by Application

2.4.1 Hospitals and Ambulatory Surgery Centers

2.4.2 Rehabilitation Centers

2.5 Opioid Tolerance Treatment Consumption by Application

2.5.1 Global Opioid Tolerance Treatment Consumption Market Share by Application (2014-2019)

2.5.2 Global Opioid Tolerance Treatment Value and Market Share by Application (2014-2019)

2.5.3 Global Opioid Tolerance Treatment Sale Price by Application (2014-2019)

3 Global Opioid Tolerance Treatment by Manufacturers

3.1 Global Opioid Tolerance Treatment Sales Market Share by Manufacturers

3.1.1 Global Opioid Tolerance Treatment Sales by Manufacturers (2017-2019)

3.1.2 Global Opioid Tolerance Treatment Sales Market Share by Manufacturers (2017-2019)

3.2 Global Opioid Tolerance Treatment Revenue Market Share by Manufacturers

3.2.1 Global Opioid Tolerance Treatment Revenue by Manufacturers (2017-2019)

3.2.2 Global Opioid Tolerance Treatment Revenue Market Share by Manufacturers (2017-2019)

3.3 Global Opioid Tolerance Treatment Sale Price by Manufacturers

3.4 Global Opioid Tolerance Treatment Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers

3.4.1 Global Opioid Tolerance Treatment Manufacturing Base Distribution and Sales Area by Manufacturers

3.4.2 Players Opioid Tolerance Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Opioid Tolerance Treatment by Regions

4.1 Opioid Tolerance Treatment by Regions

4.1.1 Global Opioid Tolerance Treatment Consumption by Regions

4.1.2 Global Opioid Tolerance Treatment Value by Regions

4.2 Americas Opioid Tolerance Treatment Consumption Growth

4.3 APAC Opioid Tolerance Treatment Consumption Growth

4.4 Europe Opioid Tolerance Treatment Consumption Growth

4.5 Middle East & Africa Opioid Tolerance Treatment Consumption Growth

5 Americas

5.1 Americas Opioid Tolerance Treatment Consumption by Countries

5.1.1 Americas Opioid Tolerance Treatment Consumption by Countries (2014-2019)

5.1.2 Americas Opioid Tolerance Treatment Value by Countries (2014-2019)

5.2 Americas Opioid Tolerance Treatment Consumption by Type

5.3 Americas Opioid Tolerance Treatment Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Opioid Tolerance Treatment Consumption by Countries

6.1.1 APAC Opioid Tolerance Treatment Consumption by Countries (2014-2019)

6.1.2 APAC Opioid Tolerance Treatment Value by Countries (2014-2019)

6.2 APAC Opioid Tolerance Treatment Consumption by Type

6.3 APAC Opioid Tolerance Treatment Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Opioid Tolerance Treatment by Countries

7.1.1 Europe Opioid Tolerance Treatment Consumption by Countries (2014-2019)

7.1.2 Europe Opioid Tolerance Treatment Value by Countries (2014-2019)

7.2 Europe Opioid Tolerance Treatment Consumption by Type

7.3 Europe Opioid Tolerance Treatment Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Opioid Tolerance Treatment by Countries

8.1.1 Middle East & Africa Opioid Tolerance Treatment Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Opioid Tolerance Treatment Value by Countries (2014-2019)

8.2 Middle East & Africa Opioid Tolerance Treatment Consumption by Type

8.3 Middle East & Africa Opioid Tolerance Treatment Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Opioid Tolerance Treatment Distributors

10.3 Opioid Tolerance Treatment Customer

11 Global Opioid Tolerance Treatment Market Forecast

11.1 Global Opioid Tolerance Treatment Consumption Forecast (2019-2024)

11.2 Global Opioid Tolerance Treatment Forecast by Regions

11.2.1 Global Opioid Tolerance Treatment Forecast by Regions (2019-2024)

11.2.2 Global Opioid Tolerance Treatment Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Opioid Tolerance Treatment Forecast by Type

11.8 Global Opioid Tolerance Treatment Forecast by Application

12 Key Players Analysis

12.1 Boehringer Ingelheim International

12.1.1 Company Details

12.1.2 Opioid Tolerance Treatment Product Offered

12.1.3 Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Boehringer Ingelheim International News

12.2 GlaxoSmithKline

12.2.1 Company Details

12.2.2 Opioid Tolerance Treatment Product Offered

12.2.3 GlaxoSmithKline Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 GlaxoSmithKline News

12.3 Teva Pharmaceutical Industries

12.3.1 Company Details

12.3.2 Opioid Tolerance Treatment Product Offered

12.3.3 Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Teva Pharmaceutical Industries News

12.4 Mylan

12.4.1 Company Details

12.4.2 Opioid Tolerance Treatment Product Offered

12.4.3 Mylan Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Mylan News

12.5 Otsuka Pharmaceutical

12.5.1 Company Details

12.5.2 Opioid Tolerance Treatment Product Offered

12.5.3 Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Otsuka Pharmaceutical News

12.6 Johnson & Johnson Services

12.6.1 Company Details

12.6.2 Opioid Tolerance Treatment Product Offered

12.6.3 Johnson & Johnson Services Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Johnson & Johnson Services News

12.7 Aurobindo Pharma

12.7.1 Company Details

12.7.2 Opioid Tolerance Treatment Product Offered

12.7.3 Aurobindo Pharma Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Aurobindo Pharma News

12.8 Pfizer

12.8.1 Company Details

12.8.2 Opioid Tolerance Treatment Product Offered

12.8.3 Pfizer Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Pfizer News

12.9 Acorda Therapeutics

12.9.1 Company Details

12.9.2 Opioid Tolerance Treatment Product Offered

12.9.3 Acorda Therapeutics Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Acorda Therapeutics News

12.10 Zydus Cadila

12.10.1 Company Details

12.10.2 Opioid Tolerance Treatment Product Offered

12.10.3 Zydus Cadila Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Zydus Cadila News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Opioid Tolerance Treatment

Table Product Specifications of Opioid Tolerance Treatment

Figure Opioid Tolerance Treatment Report Years Considere